TopFIND 4.0

Q925P2: Carcinoembryonic antigen-related cell adhesion molecule 2

General Information

Protein names
- Carcinoembryonic antigen-related cell adhesion molecule 2
- CEA-related cell adhesion molecule 2
- Biliary glycoprotein 2
- BGP-2
Gene names Ceacam2
Organism Mus musculus
Protease Family
Protease ID I43.001
Chromosome location
UniProt ID Q925P2

2

N-termini

2

C-termini

0

Cleavages

0

Substrates

Sequence

        10         20         30         40         50         60 
MELASAHLHK GQVPWFGLLL TASLLASWSP PTTAQVTVMA FPLHAAEGNN VILVVYNMMK 
        70         80         90        100        110        120 
GVSAFSWHKG STTSTNAEIV RFVTGTNKTI KGPVHSGRET LYSNGSLLIQ RVTMKDTGVY 
       130        140        150        160        170        180 
TIEMTDQNYR RRVLTGQFHV HTLLLKSNIT SNNSNPVEGD DSVSLTCDSY TDPDNITYLW 
       190        200        210        220        230        240 
SRNGESLSEG DRLKLSEGNR TLTLLNVTRN DTGPYVCETR NPVSVNRSDP FSLNIIYGPD 
       250        260        270        280        290        300 
TPIISPSDIY LHPGSNLNLS CHAASNPPAQ YFWLINEKPH ASSQELFIPN ITTNNSGTYT 
       310        320        330        340        350        360 
CFVNNSVTGL SRTTVKNITV LEPVTQPSLQ VTNTTVKELD SVTLTCLSKD RQAHIHWIFN 
       370        380        390        400        410        420 
NDTLLITEKM TTSQAGLILK IDPIKREDAG EYQCEISNPV SVKRSNSIKL EVIFDSTYDI 
       430        440        450        460        470        480 
SDVPIAVIIT GAVAGVILIA GLAYRLCSRK SRWGSDQRDL TEHKPSASNH NLAPSDNSPN 
       490        500        510        520    
KVDDVAYTVL NFNSQQPNRP TSAPSSPRAT ETVYSEVKKK 

Isoforms

- Isoform 2 of Carcinoembryonic antigen-related cell adhesion molecule 2 - Isoform 3 of Carcinoembryonic antigen-related cell adhesion molecule 2

Sequence View

        10         20         30         40         50         60 
MELASAHLHK GQVPWFGLLL TASLLASWSP PTTAQVTVMA FPLHAAEGNN VILVVYNMMK 
        70         80         90        100        110        120 
GVSAFSWHKG STTSTNAEIV RFVTGTNKTI KGPVHSGRET LYSNGSLLIQ RVTMKDTGVY 
       130        140        150        160        170        180 
TIEMTDQNYR RRVLTGQFHV HTLLLKSNIT SNNSNPVEGD DSVSLTCDSY TDPDNITYLW 
       190        200        210        220        230        240 
SRNGESLSEG DRLKLSEGNR TLTLLNVTRN DTGPYVCETR NPVSVNRSDP FSLNIIYGPD 
       250        260        270        280        290        300 
TPIISPSDIY LHPGSNLNLS CHAASNPPAQ YFWLINEKPH ASSQELFIPN ITTNNSGTYT 
       310        320        330        340        350        360 
CFVNNSVTGL SRTTVKNITV LEPVTQPSLQ VTNTTVKELD SVTLTCLSKD RQAHIHWIFN 
       370        380        390        400        410        420 
NDTLLITEKM TTSQAGLILK IDPIKREDAG EYQCEISNPV SVKRSNSIKL EVIFDSTYDI 
       430        440        450        460        470        480 
SDVPIAVIIT GAVAGVILIA GLAYRLCSRK SRWGSDQRDL TEHKPSASNH NLAPSDNSPN 
       490        500        510        520    
KVDDVAYTVL NFNSQQPNRP TSAPSSPRAT ETVYSEVKKK          10         20         30         40         50         60 
MELASAHLHK GQVPWFGLLL TASLLASWSP PTTAQVTVMA FPLHAAEGNN VILVVYNMMK 
        70         80         90        100        110        120 
GVSAFSWHKG STTSTNAEIV RFVTGTNKTI KGPVHSGRET LYSNGSLLIQ RVTMKDTGVY 
       130        140        150        160        170        180 
TIEMTDQNYR RRVLTGQFHV HTLLLKSNIT SNNSNPVEGD DSVSLTCDSY TDPDNITYLW 
       190        200        210        220        230        240 
SRNGESLSEG DRLKLSEGNR TLTLLNVTRN DTGPYVCETR NPVSVNRSDP FSLNIIYGPD 
       250        260        270        280        290        300 
TPIISPSDIY LHPGSNLNLS CHAASNPPAQ YFWLINEKPH ASSQELFIPN ITTNNSGTYT 
       310        320        330        340        350        360 
CFVNNSVTGL SRTTVKNITV LEPVTQPSLQ VTNTTVKELD SVTLTCLSKD RQAHIHWIFN 
       370        380        390        400        410        420 
NDTLLITEKM TTSQAGLILK IDPIKREDAG EYQCEISNPV SVKRSNSIKL EVIFDSTYDI 
       430        440        450        460        470        480 
SDVPIAVIIT GAVAGVILIA GLAYRLCSRK SRWGSDQRDL TEHKPSASNH NLAPSDNSPN 
       490        500        510        520    
KVDDVAYTVL NFNSQQPNRP TSAPSSPRAT ETVYSEVKKK 



Filter Information:


(REFRESH)

Directness:


Physiological Relevance:


Evidence Codes:


Methodology:


Perturbation of System:


Biological System:


Protease Assignment Confidence:


Evidence Names:


Database:


Lab:



Protein Neighborhood

Domains & Features

2 N-termini - 2 C-termini - 0 Cleavages - 0 Substrates

N-termini

C-termini

Cleavages

    Protease Position Sequence Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMIDs)

Substrates

    Substrate Position Sequence Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMIDs)